Ibrance 100 MG tablet 7S
Ended Awarded
- Contract number
- SPE2DB25FJJ17
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $8,122
Award facts
- Contract value 100% obligated
- $8,122.48 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $8,122.48 on August 12, 2025, for the supply of Ibrance 100 mg tablets (7-unit package). This is a firm fixed-price, competitively awarded contract with no set-aside designation and an ultimate completion date of September 3, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under the company's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, designated SPE2DX and valued at $999,999,999.00 through December 2026, which serves as a comprehensive global pharmaceutical support vehicle for military healthcare programs worldwide.
AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, has established itself as a critical federal vendor through its extensive portfolio of medical product deliveries to the Defense Logistics Agency and related federal healthcare systems. The company's federal contract awards demonstrate capability across a broad spectrum of pharmaceutical products including specialty medications, brand-name and generic drugs, vaccines, and medical supplies across multiple therapeutic domains. This particular delivery order for Ibrance, a oncology medication, reflects the company's role in supporting Defense Health Agency and military healthcare requirements through the DLA's pharmaceutical supply chain.
Quick answers
Who was awarded contract SPE2DB25FJJ17?
SPE2DB25FJJ17 was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on August 12, 2025.
How much is contract SPE2DB25FJJ17 worth?
The government has obligated $8,122 on SPE2DB25FJJ17.
Is contract SPE2DB25FJJ17 an order under another contract?
Yes. SPE2DB25FJJ17 is a delivery order under SPE2DB22D2206, an indefinite delivery contract.
Was contract SPE2DB25FJJ17 competed?
The extent of competition for SPE2DB25FJJ17 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award